Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?

Editorial

Ranjit S Chima et al. Crit Care Med. 2007 Oct.

. 2007 Oct;35(10):2442-3.

doi: 10.1097/01.CCM.0000284485.73320.5E.

No abstract available

Comment on

Surfactant "fortification" by topical inhibition of nuclear factor-kappaB activity in a newborn piglet lavage model.
von Bismarck P, Klemm K, Wistädt CF, Winoto-Morbach S, Uhlig U, Schütze S, Uhlig S, Lachmann B, Krause MF. von Bismarck P, et al. Crit Care Med. 2007 Oct;35(10):2309-18. doi: 10.1097/01.ccm.0000281472.47067.45. Crit Care Med. 2007. PMID: 17944019

Surfactant "fortification" by topical inhibition of nuclear factor-kappaB activity in a newborn piglet lavage model.
von Bismarck P, Klemm K, Wistädt CF, Winoto-Morbach S, Uhlig U, Schütze S, Uhlig S, Lachmann B, Krause MF. von Bismarck P, et al. Crit Care Med. 2007 Oct;35(10):2309-18. doi: 10.1097/01.ccm.0000281472.47067.45. Crit Care Med. 2007. PMID: 17944019
Surfactant for respiratory distress syndrome.
Bierman SF. Bierman SF. N Engl J Med. 1989 Sep 21;321(12):834. doi: 10.1056/NEJM198909213211216. N Engl J Med. 1989. PMID: 2671737 Clinical Trial. No abstract available.
Artificial surfactant to prevent and treat neonatal respiratory distress syndrome.
Enhorning G. Enhorning G. Pediatrics. 1980 Nov;66(5):799-800. Pediatrics. 1980. PMID: 7432889 No abstract available.
[Exogenous surfactant preparations].
Helewski K, Kowalczyk-Ziomek G, Konecki J. Helewski K, et al. Pneumonol Alergol Pol. 1998;66(1-2):127-32. Pneumonol Alergol Pol. 1998. PMID: 9658893 Review. Polish. No abstract available.
The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J, Speer CP. Wirbelauer J, et al. J Perinatol. 2009 May;29 Suppl 2:S18-22. doi: 10.1038/jp.2009.30. J Perinatol. 2009. PMID: 19399004 Review.